| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.748 | 0.001 | 0.748 | Protocollagen prolyl hydroxylase inhibitor | 0.708 0.002 DBMET03433 0.258 0.003 DBMET03434 | ||
| 0.516 | 0.024 | 0.554 | Histamine release inhibitor | 0.554 0.015 DBMET03433 0.521 0.022 DBMET03434 | DBMET03433 | |
| 0.503 | 0.026 | 0.503 | Calcium channel L-type activator | 0.484 0.034 DBMET03433 0.388 0.089 DBMET03434 | ||
| 0.451 | 0.001 | 0.451 | Egl nine homolog 1 inhibitor | 0.309 0.001 DBMET03433 | ||
| 0.441 | 0.009 | 0.441 | Sodium/bile acid cotransporter inhibitor | 0.431 0.01 DBMET03433 0.345 0.043 DBMET03434 | ||
| 0.463 | 0.037 | 0.463 | GABA C receptor rho-3 antagonist | 0.393 0.065 DBMET03433 | ||
| 0.37 | 0.01 | 0.608 | Hemostatic | 0.367 0.01 DBMET03433 0.608 0.003 DBMET03434 | DBMET03434 | |
| 0.311 | 0.035 | 0.311 | Peroxidase inhibitor | 0.304 0.036 DBMET03433 | ||
| 0.24 | 0.004 | 0.248 | HIV-1 integrase inhibitor | 0.248 0.004 DBMET03433 0.158 0.007 DBMET03434 | DBMET03433 | |
| 0.297 | 0.067 | 0.297 | Hypoxia-inducible factor 1 alpha inhibitor | 0.283 0.075 DBMET03433 0.259 0.092 DBMET03434 | ||
| 0.237 | 0.018 | 0.261 | Chelator | 0.261 0.015 DBMET03433 | DBMET03433 | |
| 0.281 | 0.065 | 0.302 | Cardiotonic | 0.302 0.055 DBMET03433 | DBMET03433 | |
| 0.304 | 0.089 | 0.407 | Cholesterol antagonist | 0.268 0.112 DBMET03433 0.407 0.048 DBMET03434 | DBMET03434 | |
| 0.265 | 0.055 | 0.265 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.058 DBMET03433 | ||
| 0.293 | 0.09 | 0.383 | Apoptosis antagonist | 0.323 0.071 DBMET03433 0.383 0.043 DBMET03434 | DBMET03434 | |
| 0.227 | 0.032 | 0.227 | Succinate dehydrogenase inhibitor | 0.219 0.036 DBMET03433 | ||
| 0.21 | 0.024 | 0.21 | GABA C receptor rho-2 antagonist | 0.177 0.045 DBMET03433 | ||
| 0.24 | 0.058 | 0.325 | Peptidyltransferase inhibitor | 0.24 0.058 DBMET03433 0.325 0.017 DBMET03434 | DBMET03434 | |
| 0.32 | 0.145 | 0.595 | Cyclophilin D inhibitor | 0.323 0.143 DBMET03433 0.595 0.028 DBMET03434 | DBMET03434 | |
| 0.266 | 0.114 | 0.514 | Antithrombotic | 0.272 0.11 DBMET03433 0.514 0.027 DBMET03434 | DBMET03434 | |
| 0.305 | 0.159 | 0.305 | 5 Hydroxytryptamine release inhibitor | 0.242 0.24 DBMET03433 0.266 0.206 DBMET03434 | ||
| 0.235 | 0.097 | 0.235 | 5 Hydroxytryptamine uptake stimulant | 0.228 0.105 DBMET03433 | ||
| 0.228 | 0.096 | 0.516 | Antioxidant | 0.301 0.061 DBMET03433 0.516 0.018 DBMET03434 | DBMET03434 | |
| 0.201 | 0.071 | 0.237 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.237 0.048 DBMET03433 | DBMET03433 | |
| 0.201 | 0.073 | 0.201 | Insulin sensitizer | 0.186 0.088 DBMET03433 | ||
| 0.184 | 0.056 | 0.184 | Phospholipase C inhibitor | 0.175 0.067 DBMET03433 | ||
| 0.251 | 0.127 | 0.662 | Transcription factor NF kappa B inhibitor | 0.298 0.095 DBMET03433 0.662 0.025 DBMET03434 | DBMET03434 | |
| 0.212 | 0.095 | 0.331 | Vasodilator | 0.239 0.076 DBMET03433 0.331 0.039 DBMET03434 | DBMET03434 | |
| 0.115 | 0.018 | 0.115 | Sphingosine 1-phosphate receptor 4 agonist | 0.078 0.038 DBMET03433 | ||
| 0.123 | 0.027 | 0.123 | Porphobilinogen synthase inhibitor | 0.083 0.045 DBMET03433 | ||
| 0.18 | 0.087 | 0.334 | Non-steroidal antiinflammatory agent | 0.213 0.061 DBMET03433 0.334 0.022 DBMET03434 | DBMET03434 | |
| 0.124 | 0.037 | 0.124 | GABA C receptor rho-1 antagonist | 0.098 0.065 DBMET03433 | ||
| 0.133 | 0.049 | 0.133 | Cystathionine beta-synthase inhibitor | 0.131 0.05 DBMET03433 | ||
| 0.191 | 0.11 | 0.191 | Aldehyde oxidase inhibitor | 0.174 0.12 DBMET03433 | ||
| 0.169 | 0.088 | 0.169 | MAP kinase kinase 5 inhibitor | 0.159 0.118 DBMET03433 | ||
| 0.187 | 0.113 | 0.187 | Nitric-oxide synthase stimulant | 0.182 0.124 DBMET03433 0.172 0.149 DBMET03434 | ||
| 0.115 | 0.043 | 0.115 | HIV-1 integrase (Overall Integration) inhibitor | 0.11 0.046 DBMET03433 | ||
| 0.132 | 0.063 | 0.152 | CC chemokine 6 receptor antagonist | 0.126 0.085 DBMET03433 0.152 0.02 DBMET03434 | DBMET03434 | |
| 0.173 | 0.106 | 0.204 | Neurotrophic factor enhancer | 0.204 0.072 DBMET03433 | DBMET03433 | |
| 0.205 | 0.141 | 0.205 | Gastrin inhibitor | |||
| 0.077 | 0.013 | 0.077 | Erythropoietin receptor agonist | 0.064 0.016 DBMET03433 | ||
| 0.078 | 0.015 | 0.109 | Plasminogen activator inhibitor antagonist | 0.109 0.009 DBMET03433 | DBMET03433 | |
| 0.147 | 0.084 | 0.237 | Thrombolytic | 0.183 0.061 DBMET03433 0.237 0.037 DBMET03434 | DBMET03434 | |
| 0.187 | 0.126 | 0.419 | Hypoglycemic | 0.189 0.123 DBMET03433 0.419 0.025 DBMET03434 | DBMET03434 | |
| 0.124 | 0.064 | 0.282 | Topoisomerase II inhibitor | 0.119 0.068 DBMET03433 0.282 0.02 DBMET03434 | DBMET03434 | |
| 0.094 | 0.034 | 0.094 | Estrogen-related receptor beta agonist | 0.093 0.035 DBMET03433 | ||
| 0.087 | 0.028 | 0.101 | HIV-1 integrase (Strand Transfer) inhibitor | 0.101 0.022 DBMET03433 0.076 0.033 DBMET03434 | DBMET03433 | |
| 0.123 | 0.065 | 0.337 | Alkylator | 0.108 0.08 DBMET03433 0.337 0.01 DBMET03434 | DBMET03434 | |
| 0.112 | 0.055 | 0.112 | DOPA decarboxylase inhibitor | 0.112 0.056 DBMET03433 | ||
| 0.09 | 0.036 | 0.09 | Glutamate decarboxylase inhibitor | 0.089 0.037 DBMET03433 | ||
| 0.085 | 0.032 | 0.108 | HIV-1 integrase (3'-Processing) inhibitor | 0.108 0.023 DBMET03433 0.056 0.052 DBMET03434 | DBMET03433 | |
| 0.09 | 0.037 | 0.09 | Histidine decarboxylase inhibitor | 0.08 0.043 DBMET03433 | ||
| 0.094 | 0.042 | 0.094 | Hematopoietic | 0.086 0.057 DBMET03433 | ||
| 0.055 | 0.003 | 0.055 | Egl nine homolog 2 inhibitor | 0.045 0.004 DBMET03433 | ||
| 0.182 | 0.132 | 0.411 | DNA damaging | 0.411 0.026 DBMET03434 | DBMET03434 | |
| 0.118 | 0.069 | 0.118 | Adenylate cyclase inhibitor | 0.111 0.075 DBMET03433 | ||
| 0.102 | 0.055 | 0.102 | Interleukin 1 beta converting enzyme inhibitor | 0.084 0.083 DBMET03433 | ||
| 0.051 | 0.004 | 0.054 | Thyroid hormone agonist | 0.054 0.004 DBMET03433 | DBMET03433 | |
| 0.109 | 0.065 | 0.122 | Electron transport complex I inhibitor | 0.122 0.044 DBMET03433 | DBMET03433 | |
| 0.168 | 0.125 | 0.426 | Free radical scavenger | 0.26 0.065 DBMET03433 0.426 0.025 DBMET03434 | DBMET03434 | |
| 0.148 | 0.106 | 0.148 | Neurotensin receptor agonist | |||
| 0.108 | 0.066 | 0.108 | GABA C receptor antagonist | |||
| 0.069 | 0.028 | 0.086 | Aldose reductase inhibitor | 0.086 0.021 DBMET03433 0.048 0.041 DBMET03434 | DBMET03433 | |
| 0.044 | 0.003 | 0.044 | Egl nine homolog 3 inhibitor | 0.028 0.004 DBMET03433 | ||
| 0.051 | 0.01 | 0.051 | Glucagon receptor antagonist | 0.035 0.016 DBMET03433 | ||
| 0.105 | 0.064 | 0.121 | Mediator release inhibitor | 0.102 0.067 DBMET03433 0.121 0.047 DBMET03434 | DBMET03434 | |
| 0.078 | 0.038 | 0.322 | Selectin antagonist | 0.078 0.038 DBMET03433 0.322 0.005 DBMET03434 | DBMET03434 | |
| 0.096 | 0.057 | 0.096 | Alcohol dehydrogenase inhibitor | 0.081 0.078 DBMET03433 | ||
| 0.184 | 0.148 | 0.254 | DNA synthesis inhibitor | 0.254 0.064 DBMET03434 | DBMET03434 | |
| 0.198 | 0.164 | 0.206 | Thyroid hormone antagonist | 0.206 0.157 DBMET03433 | DBMET03433 | |
| 0.204 | 0.172 | 0.22 | Vasodilator, peripheral | 0.22 0.154 DBMET03433 0.197 0.18 DBMET03434 | DBMET03433 | |
| 0.109 | 0.077 | 0.161 | DNA polymerase I inhibitor | 0.125 0.065 DBMET03433 0.161 0.044 DBMET03434 | DBMET03434 | |
| 0.074 | 0.043 | 0.074 | Phenylalanine 4-hydroxylase inhibitor | 0.073 0.043 DBMET03433 | ||
| 0.056 | 0.025 | 0.056 | CD45 antagonist | 0.05 0.035 DBMET03433 | ||
| 0.095 | 0.065 | 0.095 | Creatine kinase inhibitor | 0.094 0.067 DBMET03433 | ||
| 0.206 | 0.177 | 0.362 | Vasodilator, coronary | 0.362 0.05 DBMET03434 | DBMET03434 | |
| 0.064 | 0.036 | 0.064 | Heme oxygenase stimulant | 0.061 0.043 DBMET03433 | ||
| 0.064 | 0.038 | 0.064 | Purinergic P2X1 antagonist | |||
| 0.105 | 0.081 | 0.105 | Cholesterol synthesis inhibitor | 0.099 0.088 DBMET03433 | ||
| 0.128 | 0.104 | 0.128 | Phospholipase A2 inhibitor | |||
| 0.143 | 0.124 | 0.143 | Catenin beta inhibitor | |||
| 0.19 | 0.172 | 0.19 | Insulysin inhibitor | |||
| 0.171 | 0.154 | 0.209 | Superoxide dismutase inhibitor | 0.209 0.108 DBMET03433 | DBMET03433 | |
| 0.097 | 0.081 | 0.111 | Mucolytic | 0.111 0.064 DBMET03433 | DBMET03433 | |
| 0.04 | 0.025 | 0.04 | VCAM-1 antagonist | 0.037 0.036 DBMET03433 | ||
| 0.04 | 0.025 | 0.04 | VCAM antagonist | 0.037 0.036 DBMET03433 | ||
| 0.054 | 0.039 | 0.054 | DNA helicase inhibitor | |||
| 0.053 | 0.04 | 0.053 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.089 | 0.077 | 0.093 | Bile acid receptor antagonist | 0.093 0.066 DBMET03433 | DBMET03433 | |
| 0.015 | 0.004 | 0.018 | Thyroid hormone beta agonist | 0.018 0.004 DBMET03433 | DBMET03433 | |
| 0.101 | 0.09 | 0.101 | Caspase 3 inhibitor | |||
| 0.055 | 0.044 | 0.055 | Leukotriene C antagonist | |||
| 0.056 | 0.045 | 0.056 | Prostaglandin EP2 antagonist | |||
| 0.047 | 0.037 | 0.047 | Topoisomerase II beta inhibitor | 0.046 0.04 DBMET03433 | ||
| 0.035 | 0.026 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.023 DBMET03433 | DBMET03433 | |
| 0.051 | 0.042 | 0.051 | Maillard reaction inhibitor | 0.049 0.044 DBMET03433 | ||
| 0.135 | 0.125 | 0.359 | Platelet adhesion inhibitor | 0.144 0.113 DBMET03433 0.359 0.018 DBMET03434 | DBMET03434 | |
| 0.158 | 0.148 | 0.456 | Immunostimulant | 0.456 0.036 DBMET03434 | DBMET03434 | |
| 0.139 | 0.13 | 0.482 | Angiogenesis stimulant | 0.173 0.109 DBMET03433 0.482 0.013 DBMET03434 | DBMET03434 | |
| 0.092 | 0.082 | 0.092 | Folate antagonist | |||
| 0.181 | 0.172 | 0.188 | Thyroid hormone beta antagonist | 0.188 0.165 DBMET03433 | DBMET03433 | |
| 0.079 | 0.071 | 0.079 | T cell inhibitor | |||
| 0.08 | 0.074 | 0.121 | NADH dehydrogenase inhibitor | 0.121 0.028 DBMET03434 | DBMET03434 | |
| 0.067 | 0.061 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.042 | 0.036 | 0.098 | Phosphorylase inhibitor | 0.098 0.013 DBMET03434 | DBMET03434 | |
| 0.134 | 0.128 | 0.322 | Hepatoprotectant | 0.161 0.098 DBMET03433 0.322 0.024 DBMET03434 | DBMET03434 | |
| 0.102 | 0.098 | 0.102 | Cyclooxygenase 1 inhibitor | |||
| 0.008 | 0.003 | 0.009 | Insulin like growth factor 3 antagonist | 0.009 0.003 DBMET03433 | DBMET03433 | |
| 0.041 | 0.036 | 0.041 | Sphingosine 1-phosphate receptor agonist | |||
| 0.197 | 0.194 | 0.406 | Interleukin 2 agonist | 0.406 0.026 DBMET03434 | DBMET03434 | |
| 0.015 | 0.011 | 0.018 | Thyroid hormone alpha antagonist | 0.018 0.009 DBMET03433 | DBMET03433 | |
| 0.087 | 0.084 | 0.087 | GABA C receptor agonist | |||
| 0.052 | 0.05 | 0.077 | Adenine nucleotide translocase inhibitor | 0.052 0.05 DBMET03433 0.077 0.01 DBMET03434 | DBMET03434 | |
| 0.099 | 0.103 | 0.119 | Alpha-N-acetylglucosaminidase inhibitor | 0.119 0.078 DBMET03434 | DBMET03434 | |
| 0.044 | 0.049 | 0.094 | Factor IXa inhibitor | 0.094 0.011 DBMET03434 | DBMET03434 | |
| 0.077 | 0.093 | 0.181 | Monophenol monooxygenase inhibitor | 0.099 0.077 DBMET03433 0.181 0.038 DBMET03434 | DBMET03434 | |
| 0.091 | 0.11 | 0.186 | Cell adhesion inhibitor | 0.186 0.029 DBMET03434 | DBMET03434 | |
| 0.113 | 0.135 | 0.139 | Mcl-1 antagonist | 0.139 0.101 DBMET03433 | DBMET03433 | |
| 0.142 | 0.167 | 0.181 | Cyclic AMP phosphodiesterase inhibitor | 0.164 0.13 DBMET03433 0.181 0.11 DBMET03434 | DBMET03434 | |
| 0.015 | 0.043 | 0.021 | Dopamine D1 agonist | 0.021 0.02 DBMET03433 | DBMET03433 | |
| 0.097 | 0.128 | 0.113 | Toll-Like receptor antagonist | 0.113 0.096 DBMET03433 | DBMET03433 | |
| 0.054 | 0.086 | 0.192 | Topoisomerase II alpha inhibitor | 0.192 0.016 DBMET03434 | DBMET03434 | |
| 0.089 | 0.122 | 0.2 | Cyclooxygenase 3 inhibitor | 0.2 0.018 DBMET03434 | DBMET03434 | |
| 0.16 | 0.194 | 0.211 | 12-Lipoxygenase inhibitor | 0.211 0.139 DBMET03433 | DBMET03433 | |
| 0.072 | 0.111 | 0.142 | Expectorant | 0.142 0.039 DBMET03434 | DBMET03434 | |
| 0.067 | 0.107 | 0.257 | Topoisomerase I inhibitor | 0.257 0.016 DBMET03434 | DBMET03434 | |
| 0.104 | 0.153 | 0.169 | Amyloid beta aggregation inhibitor | 0.169 0.095 DBMET03433 | DBMET03433 | |
| 0.151 | 0.202 | 0.179 | Lipoxygenase inhibitor | 0.179 0.165 DBMET03433 | DBMET03433 | |
| 0.036 | 0.094 | 0.072 | Heparanase inhibitor | 0.072 0.01 DBMET03434 | DBMET03434 | |
| 0.123 | 0.181 | 0.222 | Platelet antagonist | 0.222 0.087 DBMET03434 | DBMET03434 | |
| 0.128 | 0.187 | 0.163 | Spasmolytic | 0.163 0.151 DBMET03434 | DBMET03434 | |
| 0.073 | 0.135 | 0.149 | Amylase inhibitor | 0.099 0.097 DBMET03433 0.149 0.064 DBMET03434 | DBMET03434 | |
| 0.067 | 0.13 | 0.141 | DNA intercalator | 0.141 0.047 DBMET03434 | DBMET03434 | |
| 0.115 | 0.182 | 0.159 | Hypolipemic | 0.159 0.128 DBMET03434 | DBMET03434 | |
| 0.054 | 0.127 | 0.106 | Cell adhesion molecule inhibitor | 0.106 0.031 DBMET03434 | DBMET03434 | |
| 0.169 | 0.244 | 0.319 | Toll-Like receptor agonist | 0.319 0.099 DBMET03433 | DBMET03433 | |
| 0.103 | 0.178 | 0.126 | Melanin inhibitor | 0.126 0.123 DBMET03434 | DBMET03434 | |
| 0.168 | 0.247 | 0.317 | Toll-Like receptor 7 agonist | 0.317 0.1 DBMET03433 | DBMET03433 | |
| 0.076 | 0.159 | 0.205 | Lipid peroxidase inhibitor | 0.205 0.04 DBMET03434 | DBMET03434 | |
| 0.09 | 0.177 | 0.168 | DNA repair enzyme inhibitor | 0.168 0.019 DBMET03434 | DBMET03434 | |
| 0.11 | 0.201 | 0.313 | Antiamyloidogenic | 0.313 0.048 DBMET03434 | DBMET03434 | |
| 0.101 | 0.193 | 0.153 | Interferon gamma antagonist | 0.153 0.074 DBMET03434 | DBMET03434 | |
| 0.041 | 0.144 | 0.057 | Lipocortins synthesis agonist | 0.057 0.043 DBMET03434 | DBMET03434 | |
| 0.054 | 0.162 | 0.123 | M18 aspartyl aminopeptidase inhibitor | 0.123 0.068 DBMET03433 | DBMET03433 | |
| 0.079 | 0.188 | 0.172 | Anticoagulant | 0.172 0.065 DBMET03434 | DBMET03434 | |
| 0.061 | 0.172 | 0.14 | AMP-activated protein kinase stimulant | 0.14 0.035 DBMET03434 | DBMET03434 | |
| 0.091 | 0.203 | 0.296 | Nitric oxide antagonist | 0.296 0.041 DBMET03434 | DBMET03434 | |
| 0.183 | 0.3 | 0.539 | Apoptosis agonist | 0.539 0.063 DBMET03434 | DBMET03434 | |
| 0.025 | 0.148 | 0.134 | Antineoplastic antibiotic | 0.134 0.035 DBMET03434 | DBMET03434 | |
| 0.026 | 0.151 | 0.061 | Nitric oxide donor | 0.061 0.047 DBMET03434 | DBMET03434 | |
| 0.07 | 0.197 | 0.11 | Interleukin 4 antagonist | 0.11 0.1 DBMET03434 | DBMET03434 | |
| 0.202 | 0.33 | 0.647 | Antiinflammatory | 0.272 0.243 DBMET03433 0.647 0.041 DBMET03434 | DBMET03434 | |
| 0.196 | 0.326 | 0.316 | Caspase 9 stimulant | 0.316 0.176 DBMET03434 | DBMET03434 | |
| 0.076 | 0.211 | 0.187 | Cell wall synthesis inhibitor | 0.187 0.036 DBMET03434 | DBMET03434 | |
| 0.09 | 0.229 | 0.141 | P-glycoprotein inhibitor | 0.141 0.132 DBMET03434 | DBMET03434 | |
| 0.054 | 0.193 | 0.108 | Transcription factor NF kappa B stimulant | 0.108 0.032 DBMET03434 | DBMET03434 | |
| 0.083 | 0.225 | 0.131 | Insulin secretagoues | 0.131 0.095 DBMET03434 | DBMET03434 | |
| 0.047 | 0.189 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.04 DBMET03434 | DBMET03434 | |
| 0.055 | 0.223 | 0.104 | Microtubule formation inhibitor | 0.104 0.084 DBMET03434 | DBMET03434 | |
| 0.08 | 0.248 | 0.222 | Interleukin agonist | 0.222 0.101 DBMET03434 | DBMET03434 | |
| 0.048 | 0.22 | 0.086 | Thioredoxin inhibitor | 0.086 0.069 DBMET03434 | DBMET03434 | |
| 0.042 | 0.226 | 0.119 | UDP-glucose 4-epimerase inhibitor | 0.119 0.044 DBMET03434 | DBMET03434 | |
| 0.119 | 0.305 | 0.375 | Immunomodulator | 0.375 0.052 DBMET03434 | DBMET03434 | |
| 0.133 | 0.329 | 0.258 | Caspase 3 stimulant | 0.258 0.106 DBMET03434 | DBMET03434 | |
| 0.017 | 0.216 | 0.054 | Antibiotic Aminoglycoside-like | 0.054 0.011 DBMET03434 | DBMET03434 | |
| 0.108 | 0.315 | 0.257 | Angiogenesis inhibitor | 0.257 0.118 DBMET03434 | DBMET03434 | |
| 0.014 | 0.23 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.019 DBMET03434 | DBMET03434 | |
| 0.014 | 0.254 | 0.041 | Neuraminidase (Influenza A) inhibitor | 0.041 0.04 DBMET03434 | DBMET03434 | |
| 0.081 | 0.326 | 0.159 | ATPase inhibitor | 0.159 0.087 DBMET03434 | DBMET03434 | |
| 0.032 | 0.279 | 0.106 | Bronchodilator | 0.106 0.058 DBMET03433 | DBMET03433 | |
| 0.114 | 0.368 | 0.547 | Antibacterial | 0.547 0.029 DBMET03434 | DBMET03434 | |
| 0.092 | 0.351 | 0.422 | Immunosuppressant | 0.422 0.055 DBMET03434 | DBMET03434 | |
| 0.036 | 0.302 | 0.131 | Beta glucuronidase inhibitor | 0.131 0.036 DBMET03434 | DBMET03434 | |
| 0.043 | 0.311 | 0.129 | Toll-Like receptor 4 antagonist | 0.129 0.035 DBMET03434 | DBMET03434 | |
| 0.019 | 0.301 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DBMET03434 | DBMET03434 | |
| 0.007 | 0.291 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 DBMET03434 | DBMET03434 | |
| 0.061 | 0.36 | 0.348 | Tumour necrosis factor alpha release inhibitor | 0.218 0.094 DBMET03433 0.348 0.038 DBMET03434 | DBMET03434 | |
| 0.057 | 0.377 | 0.153 | NOS3 expression enhancer | 0.153 0.07 DBMET03434 | DBMET03434 | |
| 0.031 | 0.353 | 0.096 | Multidrug resistance-associated protein 1 inhibitor | 0.096 0.086 DBMET03434 | DBMET03434 | |
| 0.051 | 0.435 | 0.295 | Alpha-glucosidase inhibitor | 0.295 0.162 DBMET03434 | DBMET03434 | |
| 0.011 | 0.424 | 0.064 | Protein 50S ribosomal subunit inhibitor | 0.064 0.028 DBMET03434 | DBMET03434 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |